J. Aberg
AuthID: R-00H-GCG
1
TITLE: Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
AUTHORS: Castagna, A; Maggiolo, F; Penco, G; Wright, D; Mills, A; Grossberg, R; J.-M Molina; Chas, J; Durant, J; Moreno, S; Doroana, M; Ait-Khaled, M; Huang, J; Min, S; Song, I; Vavro, C; Nichols, G; Yeo, JM; Aberg, J; Akil, B; ...More
PUBLISHED: 2014, SOURCE: JOURNAL OF INFECTIOUS DISEASES, VOLUME: 210, ISSUE: 3
AUTHORS: Castagna, A; Maggiolo, F; Penco, G; Wright, D; Mills, A; Grossberg, R; J.-M Molina; Chas, J; Durant, J; Moreno, S; Doroana, M; Ait-Khaled, M; Huang, J; Min, S; Song, I; Vavro, C; Nichols, G; Yeo, JM; Aberg, J; Akil, B; ...More
PUBLISHED: 2014, SOURCE: JOURNAL OF INFECTIOUS DISEASES, VOLUME: 210, ISSUE: 3